Bullish option flow detected in Crispr Therapeutics with 13,649 calls trading, 1.0x expected, and implied vol increasing over 2 points to 56.13%. Jan-24 65 calls and Dec-23 60 calls are the most active options, with total volume in those strikes near 4,800 contracts. The Put/Call Ratio is 0.28. Earnings are expected on February 20th.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on CRSP:
- The biopharma stocks to own in 2024, according to Morgan Stanley
- Crispr Therapeutics price target raised by $4 at Morgan Stanley, here’s why
- CRISPR Therapeutics (NASDAQ:CRSP) Tanks after Analyst Downgrade
- Biotech Alert: Searches spiking for these stocks today
- Unusually active option classes on open December 11th